Vetter Pharma-Fertigung GmbH & Co. KG has received a manufacturing license in accordance with the German Drug Law from the Tuebingen Regional Board for its new state-of-the-art plant, Ravensburg Vetter South. After just three years of planning and construction, the $130 million facility is now ready to begin work.

According to the company, it can offer products of the highest quality, thanks to its high level of automation and its ultra-modern Restricted Access Barrier System. In addition to dual-chamber syringes and cartridges, the new location will enable the company to fill liquid or lyophilized vials, as well as single-chamber cartridges. The new production lines are flexible, making it possible to change systems and formats, including line clearance, cleaning and disinfection. With the new facility, the company is adding services and expanding its capacity in aseptic manufacturing by approximately 30%.